The Environmental Genome Project: Ethical, legal, and social implications

Environmental Health Perspectives

Volumn 108, Issue 4, 2000, Pages 279-281

  Sharp, Richard R ^a   Barrett, J Carl ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

Environmental Genome Project; Environmental genomics; Ethics; Genetic susceptibility; Human subjects research; Informed consent

Indexed keywords

ARTICLE; DISEASE PREDISPOSITION; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL HEALTH; GENETIC POLYMORPHISM; GENOME; HUMAN; HYPERSENSITIVITY; LEGAL ASPECT; MEDICAL ETHICS; POPULATION RESEARCH; PRIORITY JOURNAL; PROPHYLAXIS; RACE; RESPONSIBILITY; SOCIAL ASPECT;

EID: 0034060831     PISSN: 00916765     EISSN: None     Source Type: Journal    
DOI: 10.1289/ehp.00108279     Document Type: Article

References (49)

1. Albers JW. Understanding gene-environment interactions [Letter]. Environ Health Perspect 105:578-580 (1997).
2. Kaiser J. Environment institute lays plans for gene hunt. Science 278:569-570 (1997).
3. Shalat SL, Hong J-Y, Gallo M. The Environmental Genome Project. Epidemiology 9:211-212 (1998).
4. Guengerich FP. The Environmental Genome Project: functional analysis of polymorphisms [Letter]. Environ Health Perspect 106:A365-A368 (1998).
5. Brown PO, Hartwell L. Genomics and human disease - variations on variation. Nat Genet 18:91-93 (1998).
6. Wilson S. Response: Environmental Genome Project [Letter]. Environ Health Perspect 106:A368-A369 (1998).
7. Khoury M. Genetic epidemiology and the future of disease prevention and public health. Epidemiol Rev 19:175-180 (1997).
8. Collins F. Shattuck lecture: medical and societal consequences of the Human Genome Project. New Engl J Med 341:28-36 (1999).
9. Chakravarti A. It's raining SNPs - hallelujah? Nat Genet 19:216-217 (1998).
10. Marshall E. The genome program's conscience. Science 274:488-490 (1996).
11. Meslin EM, Thomson EJ, Boyer JT. The ethical, legal, and social implications research program at the National Human Genome Research Institute. Kennedy Inst Ethics J 7:291-298 (1997).
12. Sharp RR, Barrett JC. The Environmental Genome Project and bioethics. Kennedy Inst Ethics J 9:199-212 (1999).
13. Loffredo CA, Silbergeld EK, Parascandola M. The Environmental Genome Project: suggestions and concerns [Letter]. Environ Health Perspect 106:A368 (1998).
14. Schulte PA, Lomax GP, Ward EM, Colligan MJ. Ethical issues in the use of genetic markers in occupational epidemiologic research. J Occup Environ Med 41:639-646 (1999).
15. Brandt-Rauf PW, Brandt-Rauf SI. Biomarkers - scientific advances and societal implications. In: Genetic Secrets: Protecting Privacy and Confidentiality in the Genetic Era (Rothstein MA, ed). New Haven, CT:Yale University Press, 1997:184-196.
16. Grandjean P, Sorsa M. Ethical aspects of genetic predisposition to environmentally-related disease. Sci Total Environ 184:37-43 (1996).
17. National Institutes of Health Office of Protection from Research Risks. Protecting Human Research Subjects: Institutional Review Board Guidebook. Washington, DC:U.S. Government Printing Office, 1993.
18. Andrews LB, Fullarton JE, Holtzman NA, Motulsky AG, eds. Assessing Genetic Risks: Implications for Health and Social Policy. Washington, DC:National Academy Press, 1994.
19. Schulte PA, Perera FP. Validation. In: Molecular Epidemiology: Principles and Practices (Schulte PA, ed). New York: Academic Press, 1993:79-107.
20. Schulte PA, Hunter D, Rothman N. Ethical and social issues in the use of biomarkers in epidemiological research. IARC Sci Publ 142:313-318 (1997).
21. Reilly P, Boshar MF, Holtzman SH. Ethical issues in genetic research: disclosure and informed consent. Nat Genet 15:16-20 (1997).
22. Schulte PA, Singal M. Ethical issues in the interaction with subjects and disclosure of results. In: Ethics and Epidemiology (Coughlin SS, Beauchamp TL, eds). New York:Oxford University Press, 1996:178-196.
23. Nelkin D, Lindee M. The DNA Mystique: The Gene as a Cultural Icon. New York:W.H. Freeman, 1995.
24. Hunter D, Caporaso N. Informed consent in epidemiologic studies involving genetic markers. Epidemiology 8:596-599 (1997).
25. Clayton EW, Steinberg KK, Khoury MJ, Thomson E, Andrews L, Kahn MJE, Kopelman LM, Weiss JO. Informed consent for genetic research on stored tissue samples. JAMA 274:1786-1792 (1995).
26. Knoppers BM, Laberge C. DNA sampling and informed consent. Can Med Assoc J 140:1023-1028 (1989).
27. Kopelman LM. Informed consent and anonymous tissue samples: the case of HIV seroprevalence studies. J Med Philos 19:525-552 (1994).
28. ASHG report. Statement on informed consent for genetic research. The American Society of Human Genetics. Am J Hum Genet 59:471-474 (1996).
29. Wilcox AJ, Taylor JA, Sharp RR, London SJ. Genetic determinism and the over-protection of human subjects. Nat Genet 21:3621 (1999).
30. Shriver M. Ethnic variation as a key to the biology of human disease. Ann Intern Med 127:401-403 (1997).
31. King PA. Race, justice, and research. In: Beyond Consent: Seeking Justice in Research (Kahn J, Mastroianni A, Sugarman J, eds). New York:Oxford University Press, 1998:88-110.
32. Caplan AL. Handle with care: race, class, and genetics. In: Justice and the Human Genome Project (Murphy TF, Lappe MA, eds). Berkeley, CA:University of California Press, 1994:30-45.
33. Rothstein MA, ed. Genetic Secrets: Protecting Privacy and Confidentiality in the Genetic Era. New Haven, CT:Yale University Press, 1997.
34. Wolf SM. Beyond "genetic discrimination": toward the broader harm of geneticism. J Law Med Ethics 23:345-353 (1995).
35. Stolberg SG. Concern among Jews is heightened as scientists deepen gene studies. New York Times, 22 April 1998,A24.
36. Struewing JP, Hartge P, Wacholder S, Baker SM, Berlin M, McAdams M, Timmerman MM, Brody LC, Tucker MA. The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. N Engl J Med 336:1401-1408 (1997).
37. Foster MW, Sharp RR, Freeman WL, Chino M, Bernsten D, Carter TH. The role of community review in evaluating the risks of human genetic variation research. Am J Hum Genet 64:1719-1727 (1999).
38. Greely HT. The control of genetic research: involving the "groups between." Houston Law Rev 33:1397-1430 (1997).
39. Weijer C. Protecting communities in research: philosophical and pragmatic challenges. Camb Q Healthcare Ethics 8:501-513 (1999).
40. Juengst ET. Groups as gatekeepers to genomic research: conceptually confusing, morally hazardous, and practically useless. Kennedy Inst Ethics J 8:183-200 (1998).
41. Reilly PR. Rethinking risks to human subjects in genetic research. Am J Hum Genet 63:682-685 (1998).
42. National Human Genome Research Institute, National Institute on Deafness and Other Communication Disorders, National Institute of Environmental Health Sciences, National Institute of General Medical Sciences. Studies of the ethical, legal and social implications of research into human genetic variation. RFA HG-99-002 In: NIH Guide for Grants and Contracts. Bethesda, MD:National Institutes of Health, 29 April 1999.
43. Reilly PR. Laws to regulate the use of genetic information. In: Genetic Secrets: Protecting Privacy and Confidentiality in the Genetic Era (Rothstein MA, ed). New Haven, CT:Yale University Press, 1997:369-391.
44. Weir RF, Lawrence SC, Fales E, eds. Genes and Human Self-Knowledge. Iowa City, IA:University of Iowa Press, 1994.
45. Lippman A. Prenatal genetic testing and screening: constructing needs and reinforcing inequities. Am J Law Med 17:15-50 (1991).
46. Edlin GJ. Inappropriate use of genetic terminology in medical research: a public health issue. Perspect Biol Med 31:47-56 (1987).
47. Juengst ET. The ethics of prediction: genetic risk and the physician-patient relationship. Genome Sci Technol 1:21-36 (1995).
48. Parker LS. Ethical concerns in the research and treatment of complex disease. Trends Genet 11:520-523 (1995).
49. Environmental Genome Project. Available: http:// www.niehs.nih.gov/envgenom/home.htm [cited 23 December 1999].